Deficiency of GFRα1 promotes hepatocellular carcinoma progression but enhances oxaliplatin-mediated anti-tumor efficacy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Deficiency of GFRα1 promotes hepatocellular carcinoma progression but enhances oxaliplatin-mediated anti-tumor efficacy

Published:2021-10 Issue: Volume:172 Page:105815
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Zhu Ha^ORCID,Huang Mingyan,Luo Jianhua,Ji Xinpei,Liu Qiuyan

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology

Reference50 articles.

1. GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Global cancer statistics 2020;CA Cancer J. Clin.,2021

2. Cancer statistics, 2021;Siegel;CA Cancer J. Clin.,2021

3. Advances in immunotherapy for hepatocellular carcinoma;Bruno;Nat. Rev. Gastroenterol. Hepatol.,2021

4. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma;Finn;N. Engl. J. Med.,2020

5. Systemic management for advanced hepatocellular carcinoma: a review of the molecular pathways of carcinogenesis, current and emerging therapies, and novel treatment strategies;Saffo;Dig. Dis. Sci.,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Claudins and hepatocellular carcinoma;Biomedicine & Pharmacotherapy;2024-02

2. Deficiency of tumor-expressed B7-H3 augments anti-tumor efficacy of anti-PD-L1 monotherapy rather than the combined chemoimmunotherapy in ovarian cancer;Pharmacological Research;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP